SANDRA VOGE: Open Payments
NPI 1598739674 · NEWARK, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$699 in 31 payments from 12 companies in 2025. Trend: 2023 $409 · 2024 $561 · 2025 $699
Food & beverage: $699
| Company | Payments | Amount |
|---|---|---|
| Phathom Pharmaceuticals, Inc. | 4 | $143 |
| Lilly USA, LLC | 5 | $112 |
| ABBVIE INC. | 5 | $90 |
| Novo Nordisk Inc | 1 | $62 |
| Ardelyx, Inc. | 3 | $56 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $52 |
| Madrigal Pharmaceuticals | 2 | $52 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $43 |
| Janssen Biotech, Inc. | 2 | $31 |
| QOL Medical, LLC | 1 | $25 |
Products named: VOQUEZNA, OMVOH, Ozempic, IBSRELA, REZDIFFRA, SKYRIZI, XIFAXAN, CREON.
Industry payments across DE — which companies pay providers there.
